J. Vanrijn et al., PROLIFERATION AND CLONAL SURVIVAL OF HUMAN LUNG-CANCER CELLS TREATED WITH FRACTIONATED-IRRADIATION IN COMBINATION WITH PACLITAXEL, International journal of radiation oncology, biology, physics, 33(3), 1995, pp. 635-639
Citations number
14
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
Purpose: This study was performed to determine the effects of a contin
uous exposure to paclitaxel (taxol) in combination with fractionated i
rradiation on cell proliferation and survival. Methods and Materials:
Human lung carcinoma cells (SW1573) were given a daily treatment with
3 Gy of x-rays during 5 days in the continuous presence of 5 nM taxol,
The surviving fraction and the total number of cells were determined
every 24 h before and immediately after irradiation. Results: Irradiat
ion with 5 x 3 Gy and 5 nM taxol cause approximately the same inhibiti
on of cell proliferation, In combination these treatments have an addi
tional effect and the cell population increases no further after the f
irst 24 h, Whereas the cells become more resistant to taxol after the
first 24 h with a minimum survival of 42%, taxol progressively reduces
the population of surviving cells in combination with x-rays when the
number of fractions increases, up to 25-fold relative to irradiation
alone, The enhancement effect of 5 nM taxol is likely to be attributed
to an inhibition of the repopulation during fractionated irradiation
and not to an increased radiosensitivity, Only after treatment with 10
or 100 nM taxol for 24 h, which is attended with a high cytotoxicity,
is moderate radiosensitization observed. Conclusion: Taxol, continuou
sly present at a low concentration with little cytotoxicity, causes a
progressive reduction of the surviving cell population in combination
with fractionated irradiation, mainly by an inhibition of the repopula
tion of surviving cells between the dose fractions.